ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)

ChengDu ShengNuo Biotec Revenue

ChengDu ShengNuo Biotec had revenue of 233.94M CNY in the quarter ending September 30, 2026, with 28.15% growth. This brings the company's total for the last twelve months to 962.54M, up 50.79% year-over-year. In the year 2025, ChengDu ShengNuo Biotec had annual revenue of 741.46M with 62.57% growth. That makes ChengDu ShengNuo Biotec the 19,921st largest company in the world by revenue and 3,656th in China.

• Revenue (ttm): 962.54M
• Revenue Growth: +50.79%
• P/S Ratio: 3.25
• Revenue / Employee: 525.12K
• Employees: 1,833
• Market Cap: 3.13B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Active Pharmaceutical Ingredient (API) 408.73M 55.2%
• Preparations 196.61M 26.5%
• Pharmaceutical Research Services 89.68M 12.1%
• Customized Production 23.33M 3.1%
• Technology Transfer 16.98M 2.3%
• Unallocated Others 5.59M 0.8%
• Consignment Processing Services 45.45K 0.0%

By Geography

Chart

• Overseas 399.07M 53.9%
• China 341.90M 46.1%

Fiscal year ended Dec 31, 2025 See the full ChengDu ShengNuo Biotec breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	741.46M	285.39M	62.57%
Dec 31, 2024	456.07M	21.05M	4.84%
Dec 31, 2023	435.02M	39.30M	9.93%
Dec 31, 2022	395.72M	9.19M	2.38%
Dec 31, 2021	386.53M	7.76M	2.05%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error